Abbreviation | Representation |
2019-nCoV | 2019 Novel Coronavirus |
95% CI | 95% Confidence Interval |
aOR | Adjusted Odds Ratio |
ACE2 | Angiotensin Converting Enzyme 2 |
ALT | Alanine Aminotransferase |
AST | Aspartate Aminotransferase |
BMI | Body Mass Index |
COVID-19 | Coronavirus Disease 19 |
CPAP | Continuous Positive Airway Pressure |
CRP | C-Reactive Protein |
ECMO | Extracorporeal Membrane Oxygen |
Emtree | Embase Subject Headings |
HELLP | Haemolysis, Elevated Liver enzyme and Low Platelet Syndrome |
ICU | Intensive Care Unit |
IFN-gamma | Interferon Gamma |
IgA | Immunoglobulin A |
IgG | Immunoglobulin G |
IgM | Immunoglobulin M |
IL-6 | Interleukin-6 |
LMWH | Low Molecular Weight Heparin |
MERS | Middle East Respiratory Syndrome |
MERS-CoV | Middle East Respiratory Syndrome Coronavirus |
MeSH | Medical Subject Headings |
NICU | Neonatal Intensive Care Unit |
NOS | Newcastle-Ottawa Scale |
OR | Odds ratio |
PECO | Population, Exposure, Comparison/Control, Outcome |
PlGF | Placental Growth Factor |
PPROM | Preterm prelabour rupture of membranes |
PRISMA | Preferred Reporting Items for Systematic Reviews and Meta-Analyses |
RT-PCR | Real-time polymerase chain reaction |
RR | Relative risk |
SARS | Severe Acute Respiratory Syndrome |
SARS-CoV-1 | Severe Acute Respiratory Syndrome Coronavirus 1 |
SARS-CoV-2 | Severe Acute Respiratory Syndrome Coronavirus 2 |
sFLT-1 | Soluble Fms-Like Tyrosine Kinase-1 |
TNF-alpha | Tumour Necrosis Factor Alpha |
WHO | World Health Organisation |